Literature DB >> 17237997

Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats.

Chad A Mauger1, Ross N Butler, Mark S Geier, Katie L Tooley, Gordon S Howarth.   

Abstract

The sucrose breath test (SBT) was employed to noninvasively assess the efficacy of probiotics in 5-fluorouracil (5-FU)-induced intestinal mucositis. Dark Agouti rats were allocated to 5 groups (n = 10): 5-FU + L. fermentum BR 11, 5-FU + L. rhamnosus GG, 5-FU + B. lactis BB 12, 5-FU + skim milk (SM), and saline + SM. Probiotics were administered by oral gavage for 10 days. Mucositis was induced on day 7 by intraperitoneal injection of 5-FU (150 mg/kg) or vehicle (saline). Rats were sacrificed 72 h after 5-FU injection. The SBT measured breath 13CO2 (expressed as percentage cumulative dose at 90 min; %CD90) on days 0, 7, and 10. %CD90 was significantly lower in 5-FU-treated controls compared with that in saline-treated controls on day 10. 5-FU caused an 83% reduction in sucrase and a 510% increase in MPO activity. The SBT detected damage induced by 5-FU and is a simple, noninvasive indicator of small bowel injury. The probiotics assessed offered no protection from mucositis at the dose tested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237997     DOI: 10.1007/s10620-006-9464-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  39 in total

Review 1.  The use of probiotics in medical practice.

Authors:  B Mombelli; M R Gismondo
Journal:  Int J Antimicrob Agents       Date:  2000-12       Impact factor: 5.283

2.  Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.

Authors:  Cesar O Freytes; Voravit Ratanatharathorn; Charles Taylor; Camille Abboud; Nancy Chesser; Alejandro Restrepo; Jorge Arango; Daniel Odenheimer
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

3.  Use of the 13C-sucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat.

Authors:  Julie M Clarke; Nicole C Pelton; Balazs H Bajka; Gordon S Howarth; Leanna C Read; Ross N Butler
Journal:  Cancer Biol Ther       Date:  2006-01-12       Impact factor: 4.742

4.  Two antioxidative lactobacilli strains as promising probiotics.

Authors:  Tiiu Kullisaar; Mihkel Zilmer; Marika Mikelsaar; Tiiu Vihalemm; Heidi Annuk; Ceslava Kairane; Ann Kilk
Journal:  Int J Food Microbiol       Date:  2002-02-05       Impact factor: 5.277

5.  Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting.

Authors: 
Journal:  Oncologist       Date:  1998

6.  Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

Authors:  E Myllyluoma; L Veijola; T Ahlroos; S Tynkkynen; E Kankuri; H Vapaatalo; H Rautelin; R Korpela
Journal:  Aliment Pharmacol Ther       Date:  2005-05-15       Impact factor: 8.171

7.  Variable response to probiotics in two models of experimental colitis in rats.

Authors:  Oren Shibolet; Fanny Karmeli; Rami Eliakim; Erwin Swennen; Patrizia Brigidi; Paulo Gionchetti; Massimo Campieri; Sara Morgenstern; Daniel Rachmilewitz
Journal:  Inflamm Bowel Dis       Date:  2002-11       Impact factor: 5.325

8.  Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.

Authors:  L A Dieleman; M S Goerres; A Arends; D Sprengers; C Torrice; F Hoentjen; W B Grenther; R B Sartor
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

9.  Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.

Authors:  Mark S Geier; Danik Tenikoff; Roger Yazbeck; Geoffrey W McCaughan; Catherine A Abbott; Gordon S Howarth
Journal:  J Cell Physiol       Date:  2005-08       Impact factor: 6.384

Review 10.  Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications.

Authors:  Gordon S Howarth
Journal:  J Nutr       Date:  2003-07       Impact factor: 4.798

View more
  11 in total

Review 1.  Gut microbiota modulation of chemotherapy efficacy and toxicity.

Authors:  James L Alexander; Ian D Wilson; Julian Teare; Julian R Marchesi; Jeremy K Nicholson; James M Kinross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

2.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

3.  Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.

Authors:  Haydn L Atkins; Mark S Geier; Luca D Prisciandaro; Ashok K Pattanaik; Rebecca E A Forder; Mark S Turner; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

4.  Small-intestinal manifestations of dextran sulfate sodium consumption in rats and assessment of the effects of Lactobacillus fermentum BR11.

Authors:  Mark S Geier; Cassie L Smith; Ross N Butler; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2008-11-13       Impact factor: 3.199

5.  Effects of commercially produced almond by-products on chemotherapy-induced mucositis in rats.

Authors:  Alexandra L Whittaker; Ying Zhu; Gordon S Howarth; Chi S Loung; Susan E P Bastian; Michelle G Wirthensohn
Journal:  World J Gastrointest Pathophysiol       Date:  2017-11-15

Review 6.  Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Authors:  Concetta Panebianco; Angelo Andriulli; Valerio Pazienza
Journal:  Microbiome       Date:  2018-05-22       Impact factor: 14.650

7.  Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.

Authors:  Chun-Yan Yeung; Wai-Tao Chan; Chun-Bin Jiang; Mei-Lien Cheng; Chia-Yuan Liu; Szu-Wen Chang; Jen-Shiu Chiang Chiau; Hung-Chang Lee
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Grape seed extract dose-responsively decreases disease severity in a rat model of mucositis; concomitantly enhancing chemotherapeutic effectiveness in colon cancer cells.

Authors:  Ker Yeaw Cheah; Gordon Stanley Howarth; Susan Elaine Putnam Bastian
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

9.  Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice.

Authors:  Tatiani Uceli Maioli; Brenda de Melo Silva; Michelle Nobre Dias; Nivea Carolina Paiva; Valbert Nascimento Cardoso; Simone Odilia Fernandes; Cláudia Martins Carneiro; Flaviano Dos Santos Martins; Simone de Vasconcelos Generoso
Journal:  J Negat Results Biomed       Date:  2014-04-11

10.  Optimisation, validation and field applicability of a 13C-sucrose breath test to assess intestinal function in environmental enteropathy among children in resource poor settings: study protocol for a prospective study in Bangladesh, India, Kenya, Jamaica, Peru and Zambia.

Authors:  Gwenyth O Lee; Robert Schillinger; Nirupama Shivakumar; Sherine Whyte; Sayeeda Huq; Silvenus Ochieng Konyole; Justin Chileshe; Maribel Paredes-Olortegui; Victor Owino; Roger Yazbeck; Margaret N Kosek; Paul Kelly; Douglas Morrison
Journal:  BMJ Open       Date:  2020-11-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.